Global and Region DTaP and Tdap Vaccines Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of DTaP and Tdap Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of DTaP and Tdap Vaccinesmarket, defines the market attractiveness level of DTaP and Tdap Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of DTaP and Tdap Vaccines industry, describes the types of DTaP and Tdap Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global DTaP and Tdap Vaccines market and the development prospects and opportunities of DTaP and Tdap Vaccines industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global DTaP and Tdap Vaccines market in Chapter 13.

    By Player:

    • Merck Sharp & Dohme Corp

    • Lanzhou Institute of Biological Products Co, Ltd

    • GlaxoSmithKline

    • Pfizer Inc

    • Sanofi Pasteur

    • Johnson & Johnson

    • Emergent BioSolutions Inc

    • Protein Sciences Corporation

    • AstraZeneca

    • Seqirus

    • Novartis AG

    • Astellas Pharma US, Inc

    By Type:

    • DTaP

    • Td

    • Tdap

    By End-User:

    • Adult

    • Pediatric

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 DTaP and Tdap Vaccines Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 DTaP and Tdap Vaccines Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 DTaP and Tdap Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 DTaP and Tdap Vaccines Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise DTaP and Tdap Vaccines Market Analysis and Outlook to 2022

    • 7.1 Global DTaP and Tdap Vaccines Consumption (2017-2022)

    • 7.2 United States DTaP and Tdap Vaccines Consumption (2017-2022)

    • 7.3 Europe DTaP and Tdap Vaccines Consumption (2017-2022)

    • 7.4 China DTaP and Tdap Vaccines Consumption (2017-2022)

    • 7.5 Japan DTaP and Tdap Vaccines Consumption (2017-2022)

    • 7.6 India DTaP and Tdap Vaccines Consumption (2017-2022)

    • 7.7 South Korea DTaP and Tdap Vaccines Consumption (2017-2022)

    8 Region and Country-wise DTaP and Tdap Vaccines Market Analysis and Outlook to 2028

    • 8.1 Global DTaP and Tdap Vaccines Consumption Forecast (2022-2028)

    • 8.2 United States DTaP and Tdap Vaccines Consumption Forecast (2022-2028)

    • 8.3 Europe DTaP and Tdap Vaccines Consumption Forecast (2022-2028)

    • 8.4 China DTaP and Tdap Vaccines Consumption Forecast (2022-2028)

    • 8.5 Japan DTaP and Tdap Vaccines Consumption Forecast (2022-2028)

    • 8.6 India DTaP and Tdap Vaccines Consumption Forecast (2022-2028)

    • 8.7 South Korea DTaP and Tdap Vaccines Consumption Forecast (2022-2028)

    9 Global DTaP and Tdap Vaccines Market Outlook by Types and Applications to 2022

    • 9.1 Global DTaP and Tdap Vaccines Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global DTaP Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Td Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Tdap Consumption and Growth Rate (2017-2022)

    • 9.2 Global DTaP and Tdap Vaccines Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Adult Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Pediatric Consumption and Growth Rate (2017-2022)

    10 Global DTaP and Tdap Vaccines Market Outlook by Types and Applications to 2028

    • 10.1 Global DTaP and Tdap Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global DTaP Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Td Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Tdap Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global DTaP and Tdap Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Adult Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Pediatric Consumption Forecast and Growth Rate (2022-2028)

    11 Global DTaP and Tdap Vaccines Import and Export Analysis (Top 5 Countries)

    • 11.1 Global DTaP and Tdap Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global DTaP and Tdap Vaccines Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 DTaP and Tdap Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global DTaP and Tdap Vaccines Market Competitive Analysis

    • 14.1 Merck Sharp & Dohme Corp

      • 14.1.1 Merck Sharp & Dohme Corp Company Details

      • 14.1.2 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product and Service

    • 14.2 Lanzhou Institute of Biological Products Co, Ltd

      • 14.2.1 Lanzhou Institute of Biological Products Co, Ltd Company Details

      • 14.2.2 Lanzhou Institute of Biological Products Co, Ltd DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Lanzhou Institute of Biological Products Co, Ltd DTaP and Tdap Vaccines Product and Service

    • 14.3 GlaxoSmithKline

      • 14.3.1 GlaxoSmithKline Company Details

      • 14.3.2 GlaxoSmithKline DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 GlaxoSmithKline DTaP and Tdap Vaccines Product and Service

    • 14.4 Pfizer Inc

      • 14.4.1 Pfizer Inc Company Details

      • 14.4.2 Pfizer Inc DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Pfizer Inc DTaP and Tdap Vaccines Product and Service

    • 14.5 Sanofi Pasteur

      • 14.5.1 Sanofi Pasteur Company Details

      • 14.5.2 Sanofi Pasteur DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Sanofi Pasteur DTaP and Tdap Vaccines Product and Service

    • 14.6 Johnson & Johnson

      • 14.6.1 Johnson & Johnson Company Details

      • 14.6.2 Johnson & Johnson DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Johnson & Johnson DTaP and Tdap Vaccines Product and Service

    • 14.7 Emergent BioSolutions Inc

      • 14.7.1 Emergent BioSolutions Inc Company Details

      • 14.7.2 Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Emergent BioSolutions Inc DTaP and Tdap Vaccines Product and Service

    • 14.8 Protein Sciences Corporation

      • 14.8.1 Protein Sciences Corporation Company Details

      • 14.8.2 Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Protein Sciences Corporation DTaP and Tdap Vaccines Product and Service

    • 14.9 AstraZeneca

      • 14.9.1 AstraZeneca Company Details

      • 14.9.2 AstraZeneca DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 AstraZeneca DTaP and Tdap Vaccines Product and Service

    • 14.10 Seqirus

      • 14.10.1 Seqirus Company Details

      • 14.10.2 Seqirus DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Seqirus DTaP and Tdap Vaccines Product and Service

    • 14.11 Novartis AG

      • 14.11.1 Novartis AG Company Details

      • 14.11.2 Novartis AG DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Novartis AG DTaP and Tdap Vaccines Product and Service

    • 14.12 Astellas Pharma US, Inc

      • 14.12.1 Astellas Pharma US, Inc Company Details

      • 14.12.2 Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Astellas Pharma US, Inc DTaP and Tdap Vaccines Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of DTaP and Tdap Vaccines

    • Figure DTaP and Tdap Vaccines Picture

    • Table Global DTaP and Tdap Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global DTaP and Tdap Vaccines Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global DTaP and Tdap Vaccines Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global DTaP and Tdap Vaccines Consumption by Country (2017-2022)

    • Figure United States DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)

    • Table Europe DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)

    • Figure China DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Japan DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)

    • Figure India DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)

    • Figure South Korea DTaP and Tdap Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global DTaP and Tdap Vaccines Consumption Forecast by Country (2022-2028)

    • Figure United States DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure China DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure India DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea DTaP and Tdap Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global DTaP Consumption and Growth Rate (2017-2022)

    • Figure Global Td Consumption and Growth Rate (2017-2022)

    • Figure Global Tdap Consumption and Growth Rate (2017-2022)

    • Figure Global Adult Consumption and Growth Rate (2017-2022)

    • Figure Global Pediatric Consumption and Growth Rate (2017-2022)

    • Figure Global DTaP Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Td Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tdap Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pediatric Consumption Forecast and Growth Rate (2022-2028)

    • Table Global DTaP and Tdap Vaccines Import by Region (Top 5 Countries) (2017-2028)

    • Table Global DTaP and Tdap Vaccines Export by Region (Top 5 Countries) (2017-2028)

    • Table Merck Sharp & Dohme Corp (Foundation Year, Company Profile and etc.)

    • Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Sharp & Dohme Corp DTaP and Tdap Vaccines Product and Service

    • Table Lanzhou Institute of Biological Products Co, Ltd (Foundation Year, Company Profile and etc.)

    • Table Lanzhou Institute of Biological Products Co, Ltd DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lanzhou Institute of Biological Products Co, Ltd DTaP and Tdap Vaccines Product and Service

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline DTaP and Tdap Vaccines Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc DTaP and Tdap Vaccines Product and Service

    • Table Sanofi Pasteur (Foundation Year, Company Profile and etc.)

    • Table Sanofi Pasteur DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur DTaP and Tdap Vaccines Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson DTaP and Tdap Vaccines Product and Service

    • Table Emergent BioSolutions Inc (Foundation Year, Company Profile and etc.)

    • Table Emergent BioSolutions Inc DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Emergent BioSolutions Inc DTaP and Tdap Vaccines Product and Service

    • Table Protein Sciences Corporation (Foundation Year, Company Profile and etc.)

    • Table Protein Sciences Corporation DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Protein Sciences Corporation DTaP and Tdap Vaccines Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca DTaP and Tdap Vaccines Product and Service

    • Table Seqirus (Foundation Year, Company Profile and etc.)

    • Table Seqirus DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Seqirus DTaP and Tdap Vaccines Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG DTaP and Tdap Vaccines Product and Service

    • Table Astellas Pharma US, Inc (Foundation Year, Company Profile and etc.)

    • Table Astellas Pharma US, Inc DTaP and Tdap Vaccines Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astellas Pharma US, Inc DTaP and Tdap Vaccines Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.